Beckman Coulter Inc. is addressing the COVID-19 pandemic with a variety of serology tests as well as diagnostics that will help physicians and drug developers treat patients with the virus.
The company’s newest COVID-19 test is the Access SARS-CoV-2 immunoglobulin M (IgM) assay
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?